Anthony Paronneau specializes in the field of life sciences and advises various pharmaceutical, biotech and medtech companies in the context of their growth operations.He has particular expertisein M&A, strategic partnerships, collaboration and licensing agreements.Anthony also represents venture capital funds and biopharmaceutical companies in various fundraising activities.Prior to joining McDermott Will & Emery, Anthony began his career witha prestigious business law firm, where he developed his proven expertise in the life sciences industry.